Soft-tissue Sarcoma: Clinical Trials

3 trials for Soft-tissue Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 21Completed 1

Follow Soft-tissue Sarcoma: new trials by email Literature Review of Soft-tissue Sarcoma trials Research Report on Soft-tissue Sarcoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma
Compound 451238 - Soft-tissue Sarcoma
Phase 1 / Phase 2CompletedRoyal Marsden NHS Foundation Trust122018-11-052026-03-02
A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma
Olaparib, Concomitant Radiotherapy - Soft-tissue Sarcoma
Phase 1CompletedInstitut BergoniƩ412016-01-012026-02-25
Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma
Pazopanib, GSK1120212 - Solid Tumors, Thyroid Cancer
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Johns Hopkins892011-10-012018-08-29

Narrower conditions

Sarcoma (3)  ·  Cholangiocarcinoma (1)  ·  Thyroid Neoplasms (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Thyroid Diseases (1)

Interventions

olaparib (1)  ·  pazopanib (1)  ·  trametinib (1)

Sponsors

Institut BergoniĆ© (1)  ·  Royal Marsden NHS Foundation Trust (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Countries

France (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Nilo Azad, MD (1)  ·  Shane Zaidi (1)

Results publications

PMID 32827353, PMID 39894354

NIH funding

2015 (1), 2017 (1)